Skip to main content
Clinical Trials/NCT04854226
NCT04854226RecruitingNot Applicable

Protein Turnover in Preterm Infants - Feeding of Target Fortified Breast Milk With Different Carbohydrate and Fat Composition to Improve Growth

Paracelsus Medical University3 sites in 1 country40 target enrollmentStarted: April 21, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
40
Locations
3
Primary Endpoint
weight gain

Study Overview

Brief Summary

The purpose of this study is to measure protein turnover rates in preterm infants.

Detailed Description

After being informed about the study and potential risks, all parents giving written informed consent the principal investigator will determine the eligibility for study entry. Patients who met the eligibility requirements will be randomized in a double-blind manner in a 1:1 ratio to fortified breast milk with higher fat composition to fortified breast milk with higher carbohydrate composition. Both groups will receive a stable protein composition. The participants will receive the intervention for 3 consecutive weeks.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Masking Description

Doctors, nurses and parents are blinded to the intervention

Eligibility Criteria

Ages
23 Weeks to 32 Weeks (Child)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Gestational age < 32 weeks
  • •Enteral nutrition >150 mL / kg / d

Exclusion Criteria

  • •gastrointestinal malformations
  • •Enterostoma
  • •short bowel syndrome
  • •necrotizing enterocolitis
  • •kidney disease
  • •Foreseeable transfer

Arms & Interventions

Macronutrient_CARB

Experimental

High carbs, low fat composition.

Intervention: Macronutrients_CARB (Dietary Supplement)

Macronutrient_FAT

Active Comparator

Low carbs, high fat composition.

Intervention: Macronutrient_FAT (Dietary Supplement)

Outcomes

Primary Outcomes

weight gain

Time Frame: daily for 3 weeks

weight gain in gram

Protein turnover and net protein gain

Time Frame: weekly for 3 weeks

Tracer N15 labelled amino acids

Protein excretion

Time Frame: weekly for 3 weeks

Urinary urea in mg/dL and urine volume in mL will be combined to report protein excretion per urine sample (g/kg/d).

Secondary Outcomes

  • Nutritional intake(daily for 3 weeks)
  • head circumference(daily for 3 weeks)
  • body length(daily for 3 weeks)
  • body composition(weekly for 3 weeks)

Investigators

Sponsor
Paracelsus Medical University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Niels Rochow, MD, PhD

Principal Investigator

Paracelsus Medical University

Study Sites (3)

Loading locations...

Similar Trials